Drawing for PHARM GAME

USPTO serial 76276798

PHARM GAME

Reviewed by CopyMark Law Group

Reg. 2555864Status 710
Filing date
Status date
Registration date
Apr 2, 2002
Examiner
SHIH, SALLY
Law office
GENERIC WEB UPDATE

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with PHARM GAME?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
028educational board games used in employee training programsSECTION 8 - CANCELLEDDec 15, 1995

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 14, 2022CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Apr 2, 2021REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jan 14, 2015ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Mar 28, 2012NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Mar 28, 2012RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Mar 28, 201289AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Mar 28, 2012APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 19, 2012E89RTEAS SECTION 8 & 9 RECEIVED—
Mar 19, 2012TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 8, 2012ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 8, 2012REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 11, 2007C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Dec 3, 2007PLGLASSIGNED TO PARALEGAL—
Nov 29, 2007E815TEAS SECTION 8 & 15 RECEIVED—
Aug 9, 2007TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 14, 2007CFITCASE FILE IN TICRS—
Jan 14, 2004TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 2, 2002R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 8, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 19, 2001NPUBNOTICE OF PUBLICATION—
Oct 4, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 4, 2001ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Sep 10, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 5, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance